2024 annual financial data
Telomir Pharmaceuticals 2024 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -12,242,174 USD and net income was -16,532,716 USD.
Operating cash flow was -5,070,428 USD.
Get free Telomir Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -12,242,174 USD
- Net income
- -16,532,716 USD
- Operating cash flow
- -5,070,428 USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Telomir Pharmaceuticals financial years